AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Enerpac Tool Group, you need to be comfortable with a relatively steady industrial story where disciplined capital allocation does some of the heavy lifting. The latest quarter showed higher sales and earnings, and management nudged full-year sales guidance slightly tighter while outlining US$132 million to US$139 million of operating profit for 2026. That refinement looks more like fine tuning than a reset, so it does not radically change near term catalysts, which still hinge on execution, margin resilience and how effectively the company converts its solid Return on Equity into per share earnings. The completed US$80.44 million buyback, retiring just under 4% of the share base, supports that per share focus, but it also raises the stakes if earnings growth slows or industrial demand softens.
However, investors should watch how the lower profit guidance interacts with this heavier use of cash. Despite retreating, Enerpac Tool Group's shares might still be trading 20% above their fair value. Discover the potential downside here.Explore 3 other fair value estimates on Enerpac Tool Group - why the stock might be worth just $39.11!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com